Survival after diagnosis with AIDS-related neurological illnesses has improved since the advent of HAART, according to an abstract presented to the eleventh European AIDS Conference (EACS). Furthermore, patients on ARV regimens containing a higher number of drugs that crossed the ‘blood-brain barrier’ and got into the central nervous system (CNS) had better survival rates.

This Treataware fact sheet looks at the various neurological and psychological illnesses that affect people with HIV/AIDS including AIDS dementia complex, toxoplasmosis, PML, lymphoma and depression.